8legs: Medicines and healthcare products regulatory agency

#1 out of 1

Antidepressant recall chaos: How to identify affected prescriptions

MHRA orders recall of sertraline boxes after a packaging error caused some to contain a citalopram strip.
Box batch V2500425 with May 2028 expiry is potentially affected, and patients should check packaging for the rogue strip.
Experts warn that combining SSRIs can trigger serotonin syndrome, a potentially fatal condition.
If affected, patients should stop taking the medicine and contact their pharmacy immediately.
Sertraline users should watch for signs of serotonin syndrome, such as high blood pressure, fast heart rate, confusion, or seizures.
MHRA advised stop-supply of affected batch and return stock to suppliers.
Experts noted the recall followed a packaging error at the manufacturing site during secondary packing.
Patients over 65, under 18, and those with heart or liver conditions require particular caution.
GPs and clinicians should review treatment and consider a new prescription if needed.
The recall follows increasing concerns about medication safety and supplier accountability.

Vote 0